This virtual dialogue took place on Monday, May 4, 2020 and was Part 1 of a three-part series called Innovation on Demand: Strategies for Addressing Family Violence During COVID-19. The recording and transcript, along with resources shared by the presenters, are available through the links below.
Click here to view the recording of Innovation on Demand Part 1.
Click here to download the closed-captioning transcript (Word).
Click here to learn more, and to access resources from parts 2 and 3.
Materials shared by the QIC-DVCW:
Tip Sheet 1 – 10 Creative Ways to Engage Children and Youth Through Virtual Activities – English (PDF)
Materials shared by Child Witness to Violence Project:
Informed Consent to Telehealth Counseling Form (PDF)
Materials shared by House of Ruth Maryland:
Virtual Abuse Intervention Program Consent Form – English (Word)
Virtual Abuse Intervention Program Consent Form – Spanish (Word)
Virtual Abuse Intervention Program Participant Survey Form – English (Word)
Virtual Abuse Intervention Program Partner Survey Form – English (Word)
Virtual Abuse Intervention Program Contract – English (Word)
Virtual Abuse Intervention Program Contract – Spanish (Word)
In Part 1, presenters share how they offer virtual services with families impacted by domestic violence during the COVID-19 pandemic. Panelists discuss equity and safety issues with telehealth counseling, and share what it takes to create safer virtual environments with children and adult survivors of domestic violence and abusive partners.
Questions? Accessibility Needs? Please contact Jess Fournier at email@example.com
These webinars are funded through the Department of Health and Human Services, Administration for Children and Families, Children’s Bureau, Grant #90CA1850-01, and Grant Number 90EV0434-01-00 from the Administration on Children, Youth and Families, Family and Youth Services Bureau, U.S. Department of Health and Human Services. The content of these webinars does not necessarily reflect the view or policies of the funder, nor does mention of trade names, commercial products or organizations imply endorsement by the US Department of Health and Human Services.